Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Peralta-Acon
Cost Effectiveness of Tofacitinib as Second Line Treatment vs Using Biological Therapies in the Treatment of Moderate Rheumatoid Arthritis After Failure of Dmards in Panama in 2014
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms30 - Cost Analysis for Different Anti-Rheumatoid Biological Treatments After Failure of Conventional Dmards in Patients With Moderate to Severe Rheumatoid Arthritis in the Kingdom of Saudi Arabia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost-Effectiveness of Alternative Treatment Sequences in Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Experience With Tofacitinib in the Treatment of Resistant Rheumatoid Arthritis
Modern Rheumatology Journal
Cost-Effectiveness Analysis of Baricitinib Versus Adalimumab for the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Spain
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Pms51 - Cost-Effectiveness of Tofacitinib-Containing Sequences for Rheumatoid Arthritis Patients in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Early Treatment With Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients With Established Rheumatoid Arthritis
Advances in Therapy
Medicine
Pharmacology
Pharmacoeconomic Analysis of Using Biological Agents in the Treatment of Rheumatoid Arthritis
Modern Rheumatology Journal
